Prostate radiotherapy for metastatic hormone sensitive prostate cancer-myth or reality?
作者信息
Onal Cem
机构信息
Department of Radiation Oncology, Baskent University Faculty of Medicine, Adana, Turkey.
出版信息
Transl Cancer Res. 2019 Nov;8(7):2508-2509. doi: 10.21037/tcr.2019.05.11.
Abstract
摘要
相似文献
1
Prostate radiotherapy for metastatic hormone sensitive prostate cancer-myth or reality?
Transl Cancer Res. 2019 Nov;8(7):2508-2509. doi: 10.21037/tcr.2019.05.11.
2
WHO SHOULD RECEIVE RADIOTHERAPY IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER?
Acta Clin Croat. 2019 Nov;58(Suppl 2):36-41. doi: 10.20471/acc.2019.58.s2.06.
3
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.
Eur Urol. 2019 Jul;76(1):115-124. doi: 10.1016/j.eururo.2019.02.003. Epub 2019 Feb 28.
4
[Modern treatment of metastatic hormone-sensitive prostate cancer].
Orv Hetil. 2018 Oct;159(41):1664-1671. doi: 10.1556/650.2018.31218.
5
Current treatment options for newly diagnosed metastatic hormone-sensitive prostate cancer-a narrative review.
Transl Androl Urol. 2021 Oct;10(10):3918-3930. doi: 10.21037/tau-20-1118.
6
Current status of primary pharmacotherapy and future perspectives toward upfront therapy for metastatic hormone-sensitive prostate cancer.
Int J Urol. 2016 May;23(5):360-9. doi: 10.1111/iju.13091. Epub 2016 Apr 8.
7
Prostate radiotherapy in newly diagnosed metastatic prostate cancer.
Curr Opin Urol. 2019 Nov;29(6):620-628. doi: 10.1097/MOU.0000000000000675.
8
Targeting Metastatic Hormone Sensitive Prostate Cancer: Chemohormonal Therapy and New Combinatorial Approaches.
J Urol. 2019 May;201(5):876-885. doi: 10.1097/JU.0000000000000117.
9
Hormone and radiotherapy versus hormone or radiotherapy alone for non-metastatic prostate cancer: a systematic review with meta-analyses.
Clin Oncol (R Coll Radiol). 2014 Oct;26(10):e21-46. doi: 10.1016/j.clon.2014.06.016. Epub 2014 Jul 21.
10
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer.
Eur Urol. 2021 Feb;79(2):263-282. doi: 10.1016/j.eururo.2020.09.046. Epub 2020 Oct 7.
本文引用的文献
1
Prostate Radiotherapy for Metastatic Hormone-sensitive Prostate Cancer: A STOPCAP Systematic Review and Meta-analysis.
Eur Urol. 2019 Jul;76(1):115-124. doi: 10.1016/j.eururo.2019.02.003. Epub 2019 Feb 28.
2
Outcome of loco-regional radiotherapy in metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.
Strahlenther Onkol. 2019 Oct;195(10):872-881. doi: 10.1007/s00066-019-01429-6. Epub 2019 Jan 30.
3
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet. 2018 Dec 1;392(10162):2353-2366. doi: 10.1016/S0140-6736(18)32486-3. Epub 2018 Oct 21.
4
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial.
Eur Urol. 2019 Mar;75(3):410-418. doi: 10.1016/j.eururo.2018.09.008. Epub 2018 Sep 25.
5
NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection.
J Natl Compr Canc Netw. 2018 May;16(5S):620-623. doi: 10.6004/jnccn.2018.0036.
6
Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour.
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):941-949. doi: 10.1007/s00259-017-3631-6. Epub 2017 Jan 31.
7
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
N Engl J Med. 2015 Aug 20;373(8):737-46. doi: 10.1056/NEJMoa1503747. Epub 2015 Aug 5.
8
Radical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare Analysis.
J Urol. 2015 Aug;194(2):378-85. doi: 10.1016/j.juro.2015.02.084. Epub 2015 Feb 21.
9
Identifying optimal candidates for local treatment of the primary tumor among patients diagnosed with metastatic prostate cancer: a SEER-based study.
Eur Urol. 2015 Jan;67(1):3-6. doi: 10.1016/j.eururo.2014.08.056. Epub 2014 Sep 10.
10
Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.
J Clin Oncol. 2007 Aug 1;25(22):3281-7. doi: 10.1200/JCO.2006.09.2940.
Zotero 插件